LRMR vs MSCI · $204.9M cap vs P/E 37, rev $1.72B
Larimar Therapeutics Inc (LRMR) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Larimar Therapeutics Inc (LRMR) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
LRMR does not have a complete income-statement cache yet.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
LRMR currently screens at market cap $204.9M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the LRMR and MSCI stock pages for the full models.
Not investment advice.